BRITANNIA LIFE SCIENCES Cash Flow Conversion Efficiency

Latest as of December 2025: 0.057x

BRITANNIA LIFE SCIENCES cash flow conversion efficiency. Based on the latest financial reports, BRITANNIA LIFE SCIENCES (L020) has a cash flow conversion efficiency ratio of 0.057x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€989.01K ≈ $1.16 Million USD) by net assets (€17.23 Million ≈ $20.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of BRITANNIA LIFE SCIENCES (2022–2025)

Cash flow conversion efficiency of BRITANNIA LIFE SCIENCES from 2022 to 2025. This chart illustrates how BRITANNIA LIFE SCIENCES's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of BRITANNIA LIFE SCIENCES for real-time trading data and today's change.

BRITANNIA LIFE SCIENCES Cash Flow Conversion Ratio Explained

BRITANNIA LIFE SCIENCES cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

BRITANNIA LIFE SCIENCES Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BRITANNIA LIFE SCIENCES ranked by their cash flow conversion efficiency. Also see market cap of BRITANNIA LIFE SCIENCES for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
PT Sunter Lakeside Hotel Tbk JK:SNLK	0.004x
Basel Medical Group Ltd Ordinary Shares NASDAQ:BMGL	-0.250x
Hanwha Corp. Pfd. Series 1 KO:000885	0.114x
Jiankun International Bhd KLSE:8923	-0.018x
FIRST LITHIUM MINERALS F:X28	-0.160x
Firebrick Pharma Ltd AU:FRE	-0.543x
Utilico Emerging Markets Ltd LSE:UEM	0.009x
E Investment & Development KO:093230	-0.020x

Annual Cash Flow Conversion Efficiency for BRITANNIA LIFE SCIENCES (2022–2025)

The table below shows the annual cash flow conversion efficiency of BRITANNIA LIFE SCIENCES from 2022 to 2025. Review BRITANNIA LIFE SCIENCES free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	€6.30 Million ≈ $7.37 Million	€-2.62 Million ≈ $-3.06 Million	-0.416x	-232.59%
2024-03-31	€6.67 Million ≈ $7.80 Million	€2.09 Million ≈ $2.45 Million	0.314x	+72.71%
2023-03-31	€11.06 Million ≈ $12.93 Million	€2.01 Million ≈ $2.35 Million	0.182x	-64.44%
2022-03-31	€5.48 Million ≈ $6.41 Million	€2.80 Million ≈ $3.27 Million	0.511x	--

About BRITANNIA LIFE SCIENCES

F:L020 Germany Biotechnology

Market Cap

$5.69 Million

€4.87 Million EUR

Market Cap Rank

#28245 Global

#2431 in Germany

Share Price

€0.03

Change (1 day)

+0.00%

52-Week Range

€0.02 - €0.05

All Time High

€0.15